Hives. Urticaria, unspecified
Conditions
Interventions
Intervention 1: Intervention group: For the first group of patients, treatment includes only antihistamines.Two antihistamines is given twice daily and the type of them is prescribed based on the pati
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: For at least two days of week patients must have urticaria lesions and these lesions must remain for at least 6 weeks. Age between 18 to 45 years old
Exclusion criteria
Exclusion criteria: Serious comorbidities (such as malignancies, mental illness, hepatitis, endocrine or other acute and chronic systemic diseases) Taking any drug other than antihistamines Patients with vasculitis Patients with urticaria due to autoimmune diseases A history of severe gastrointestinal diseases such as indigestion and malabsorption Patients taking corticosterone for any reason A history of asthma and allergies in the patients and their first degree relatives Patients with severe mental problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Itching severity. Timepoint: first visit - 8 Week after treatment. Method of measurement: Questionnaire and visit.;Urticaria activity score over 7 days (UAS7). Timepoint: first visit -- 8 Week after treatment. Method of measurement: Questionnaire and visit.;Number of hives. Timepoint: first visit - 8 Week after treatment. Method of measurement: Questionnaire and visit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: first visit snd 8 Week after treatment. Method of measurement: dermatology Quality Life Index.;Complications. Timepoint: 8 Week after treatment. Method of measurement: interview.;Tolerance of treatment and satisfaction. Timepoint: 8 Week after treatment. Method of measurement: interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShokoufeh Sharifi
Iran University of Medical Sciences
Outcome results
None listed